drugset / Trial / NCT03379233

A Randomized Study to Evaluate the Effect of Reminder Notifications and Motivational/Adaptive Messaging on Treatment Adherence

NCT03379233

Phase 3 Terminated 7 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupOpen-labelDevice feasibility

Summary

This study was evaluating the effect of reminder notifications and motivational/adaptive messages on treatment adherence behavior in subjects with COPD. The effect will be measured over 24 weeks on the subject's on time treatment adherence and total treatment adherence. The delivery of the medication and tracking of inhaler use is done by the Concept2 inhaler. The reminder notification, feedback on inhaler use and motivational messages are provided by the patient application, who is receiving the inhaler use information from the Concept2 inhaler.

Timeline

Start
2018-07-11
Primary completion
2019-01-22
Completion
2019-01-22

Drugs

EvaluationDrugModalityDoseRoute
Background Glycopyrronium Unknown 50 ug Inhaled
Background Indacaterol Other / unclassified 110 ug Inhaled